NASDAQ NMS - GLOBAL MARKET · ARTV
+1.07% · +$0.1000 · Vol 260.7K
After hours · updated 16:00:14 ET
Artiva Biotherapeutics Inc

Artiva Biotherapeutics Inc

Biotechnology
$9.41
+ Add to watchlist
Card

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is ARTV moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Artiva Biotherapeutics Inc
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed since
2024
Employees
106
Country
US

Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$9.31
Day high
$9.77
Day low
$9.20
Previous close
$9.31
52W high
$10.27
-8.33% from high
52W low
$7.42
70% of range
Market cap
$452.4M
EPS
$-3.5300
Shares out
48.6M
Volume
260.7K
VWAP
$9.46
Price history computed in-house
1W
-2.08%
1M
+26.82%
SMA 50 $9.32 · above
SMA 200 $9.32 · above
52W position 70%
Veridion warehouse edge

Warehouse intelligence for ARTV.

Veridion Score
71
0: 561: 392: 793: 504: 815: Not reported
Congress 30d
0
No recent disclosure on file.
Insider activity
See Form 4 panel below.
13F holders
None on file
Capital Web snapshots checked.
Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Source: Veridion methodology
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

ARTV insider activity

Artiva Biotherapeutics Inc

Score
Coverage building
Pressure
Net buying
Filings
33
Buys / sells
10 / 23
Net value
$127.8M
Insiders
8
Named filers
RL
RA Capital Healthcare Fund LP
Insider
Leadership
RH
Raymon Heather
Insider
Leadership
BS
Banerjee Subhashis
Insider
Leadership
Cluster

2 insiders bought in the last 90 days

Net pressure

Net buying: $127.8M across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Filing dateTrade dateInsiderTitleTypePriceQtyOwnedValueReceipt
2026-06-162026-06-16RA Capital Healthcare Fund LPInsiderbuy$8.89124,89316,763,043$1.1MSEC Form 4
2026-06-162026-06-15RA Capital Healthcare Fund LPInsiderbuy$8.9915,41416,638,150$139KSEC Form 4
2026-06-162026-06-12RA Capital Healthcare Fund LPInsiderbuy$8.57391,01916,622,736$3.4MSEC Form 4
2026-06-112026-06-11RA Capital Healthcare Fund LPInsiderbuy$7.91548,58016,231,717$4.3MSEC Form 4
2026-06-112026-06-10RA Capital Healthcare Fund LPInsiderbuy$7.0010315,683,137$721SEC Form 4
Full Form 4 history requires Sovereign

Showing 5 recent rows. Sovereign unlocks 28 additional rows, full sorting, and the named-filer history.

Upgrade to Sovereign · $25/mo
Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

ARTV contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ARTV in this window.
Lobbying spend

ARTV lobbying filings, year to date.

Registered lobbying filings matched to Artiva Biotherapeutics Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ARTV in this window.
Latest news · ARTV
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for ARTV.
Options
Sovereign unlock shows live options positioning for ARTV.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.